We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Head and neck
6005
Poster (Digital)
Clinical
Sarcopenia in oropharyngeal cancer treated with curative radiotherapy: time for a tailored approach?
Mattia Zaffaroni, Italy
PO-1172
Re-irradiation in H&N cancer: A retrospective outcome analysis using a single institutional database
Daniel Zwahlen, Switzerland
PO-1173
Clinical outcomes of ipsilateral versus bilateral neck irradiation for unilateral tonsillar cancer
Eunyeong Yang, Korea Republic of
PO-1174
Outcomes in oropharyngeal squamous cell carcinomas based on gross tumour volume
Darragh Browne, Ireland
PO-1175
The role of SABR in the management of oligometastatic and recurrent head and neck cancers
Ahmed Allam Mohamed, Germany
PO-1177
Elective node irradiation and perineural invasion in salivary gland tumors: the MedAustron approach
Ankita Nachankar, Austria
PO-1178
Proton treatment planning: How many H&N patients qualify for proton plan calculation in Ireland?
Brendan McClean, Ireland
PO-1180
Clinical outcomes after re-irradiation with dose painting of head and neck cancer
Einar Dale, Norway
PO-1181
Feasibility of Temporally Feathered Radiation Therapy (TFRT) planning in head and neck cancers
sanjay hunugundmath, India
PO-1183
Hypofractionated re-irradiation for locoregionally recurrent head and neck cancer
Carlotta Becherini, Italy
PO-1184
Long term effectiveness of intraoperative radiotherapy boost in adjuvant treatment for oral cancers
Aleksandra Napieralska , Poland
PO-1185
Predictors for laryngo-esophageal function preservation after radiotherapy for hypopharyngeal cancer
AYA Nakajima, Japan
PO-1186
older age: a factor of worse prognosis and tolerance in nasopharyngeal cancer
Nabila SELLAL, Morocco
PO-1188
A retrospective review: risk factors associated with osteoradionecrosis in Head and Neck cancer
Theresa O'Donovan, Ireland
PO-1189
Health related QoL in patients with NPC treated with NACT followed by dysphagia-optimised CRT
Ahitagni Biswas, India
PO-1191
Pattern of practice in elderly patients with HPV positive oropharyngeal cancer: a multicenter study
Pierluigi Bonomo, Italy
PO-1193
Social life functioning evolution during chemoradiotherapy for nasopharyngeal carcinoma
Nejla Fourati, Tunisia
PO-1194
Should we delineate lacrimal gland during nasopharyngeal carcinoma radiotherapy?
Nejla Fourati, Tunisia
PO-1195
Submandibular gland transfer to preserve salivary function: a prospective study of 16 HN patients
Vitali Moiseenko, USA
PO-1196
Dosimetric predictors of persistent xerostomia after IMRT for nasopharyngeal carcinoma
Nejla Fourati, Tunisia
PO-1197
SBRT can defer the need for systemic therapy in oligometastatic iodine-refractory thyroid cancer
GABRIELE SIMONTACCHI, Italy
PO-1198
Challenges of delineation of hypopharyngeal tumors
Ellen Rylander, Sweden
PO-1199
Preliminary evaluation of mucosal melanoma of the head and neck with carbon ion radiotherapy
Azusa Hasegawa, Japan
PO-1200
Prognostic impact of second primary cancers in laryngeal cancer patients treated with radiotherapy
Chiyoko Makita, Japan
PO-1201
Robotic radiosurgery for benign temporal bone paragangliomas: a single-center experience
Sofia Ramos, Portugal
PO-1202
Reirradiation in head and neck cancer. Who would benefit? Retrospective analysis of our experience
Raquel Granado, Spain
PO-1203
Racial Disparities in Survival for Human Papillomavirus Associated Oropharyngeal Cancer
Sujith Baliga, USA
PO-1204
MRI changes in Muscles of Mastication during radiotherapy: ​secondary analysis of PREDICT-HN study
Maura O’Connell, Australia
PO-1205
NACT followed by cisplatin-enhanced dysphagia-optimised IMRT in nasopharyngeal cancer-phase 2 trial
Ahitagni Biswas, India
PO-1206
Intensity-modulated radiotherapy for inoperable/unresectable recurrent differentiated thyroid cancer
Jia-Shing Wu, Taiwan
PO-1207
Is bilateral RT necessary for patients with unilateral SCC-CUP of the head and neck region?
Laura Oebel, Germany
PO-1208
Sentinel lymph nodes identification with SPECT/CT for HNSCC radiotherapy: a multicentric dummy run
Jean-Francois Daisne, Belgium
PO-1209
Intensity modulated radiotherapy of nasopharyngeal carcinomas: locoregional failure patterns
Nejla Fourati, Tunisia
PO-1210
Adjuvant Radiotherapy in Node-negative Parotid Gland Malignancies: A Multi-institutional Analysis
JUNG BIN PARK, Korea Republic of
PO-1211
How did treatment affect body image in patients treated for Head and Neck Cancers?
Nejla Fourati, Tunisia
PO-1212
A comparative analysis of two fractionation protocol of simultaneous integrated boost-IMRT for LAHNC
Pragya Singh, India
PO-1213
Reactive enteral feeding in head and neck radiotherapy: Analysis of screen failures from ongoing RCT
Meenakshi Jeeva, India
PO-1214
Evaluation of Sexual Health in patients with Head and Neck Cancers
Nejla Fourati, Tunisia
PO-1215
Quality of weight loss during chemo-radiotherapy of nasopharyngeal carcinoma
Nejla Fourati, Tunisia
PO-1216
A systematic review of radiotherapy-associated changes in saliva composition
Michal Staruch, Switzerland
PO-1217
Multi-imaging Adaptive RT for head and neck cancer: early results of RadiomicART trial (NCT05081531)
Maria Ausilia Teriaca, Italy
PO-1218
Dosimetric comparison of conventional and hippocampus-sparing VMAT plans in nasopharyngeal carcinoma
Monika Peternel, Slovenia
PO-1219
Feasibility and compliance of StrataXRT in treatment of radiation dermatitis in head and neck cancer
Gemma Mckee, New Zealand
PO-1220
Radiation induced myopathy of neck muscles with IMRT - A study of dosimetry and clinical correlation
Himanshi Khattar, India
PO-1223
A framework to link 3D radiotherapy to 2D ophthalmological findings
Mohamed Kilany Hassan, The Netherlands
PO-1224
Dysphagia and treatment prolongation due to CRT for upper aerodigestive tract malignancies
Petros Alexidis, Greece
PO-1225
A multicenter real-world study reviewing relevance between CCRT and CVA for NPC: In the IMRT era
JENG-YOU WU, Taiwan
PO-1227
The accuracy of staging head and neck MRI versus histopathology in patients with laryngeal cancer
Issa Mohamad, Jordan
PO-1228
Preliminary clinical outcomes of accelerator-based BNCT for recurrent head and neck cancer
Keiji Nihei, Japan
PO-1230
Biomarkers of neoadjuvant Multikine (LI) treatment outcome in locally advanced head & neck carcinoma
József Timar, Hungary
PO-1231
The impact of weight loss in head and neck cancer patients treated with chemo-radiotherapy
Nadia Di Muzio, Italy
PO-1232
Standardized radiological extranodal extension assessment and prognosis in oropharyngeal carcinoma
Frederik Wesseling, The Netherlands
PO-1234
Systematic review of the methodological conduct of Head and Neck SCC outcome prediction models
Christian Rønn Hansen, Denmark
PO-1236
Efficacy and tolerance of stereotactic re-irradiation in the treatment of head and neck cancers
Chloé Delerue, France
PO-1237
Metastatic LNs distribution and proposed individualized prophylactic neck irradiation in NPC
Lei Wang, China
PO-1239
Large primary tumours of oropharyngeal cancer may benefit from radiation dose escalation
Anna Embring, Sweden
PO-1240
Patient Reported Outcomes Based on EQ-5D-5L Questionnaires in Head and Neck Cancer Patients
Tanja Sprave, Germany
PO-1242